Related Experiment Video
Updated: Jun 25, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper
Benjamin B Swart1, Charles Reznikoff, Katie Steen
1From the Addiction Medicine Fellow, University of Minnesota, Minneapolis, MN (BBS); Associate Professor of Medicine, University of Minnesota, Internal Medicine and Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN (CR); and Faculty Physician, Addictive Recovery Services, Veteran's Affairs Medical Center, Minneapolis, MN (KS).
Abstract:
This case report highlights a 36-year-old male without history of psychiatric disease, chronic pain, or substance use disorder who developed severe substance use disorder per Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition criteria to kratom. He was successfully treated with sublingual buprenorphine after a 3-year period of intermittent withdrawal management and trials of oral and extended-release injectable naltrexone. After a period of abstinence from kratom, he was tapered from buprenorphine using 2 monthly injections of 100 mg extended-release buprenorphine. His case underscores some of the current uncertainties around kratom use disorder diagnosis and treatment.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Drug Abuse and Addiction: Pharmacological Phenomena
Desensitization and Tachyphylaxis
Drug Dependence